Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Acta Academiae Medicinae Sinicae ; (6): 2-6, 2003.
Article in Chinese | WPRIM | ID: wpr-301911

ABSTRACT

<p><b>OBJECTIVE</b>To study the ectopic osteogenesis of tissue engineered bone with recombinant human bone morphogenetic protein/transforming growth factor-beta (rhBMP/TGF-beta) or WO-1 slow-released factors.</p><p><b>METHODS</b>Partial demineralized freeze-dried bone (PDFDB) of pig was used as scaffold material. rhBMP/TGF-beta or WO-1 were pre-coated on the surface of material by means of vacuum negative pressure absorption, and then coated with polylactic acid (PLA) to make slow-released material. There were six group: PDFDB material (group A); PDFDB combined with osteoblasts (group B); PDFDB material with rhBMP/TGF-beta slow-released system (group C); PDFDB material combined with rhBMP/TGF-beta slow-released system osteoblasts (group D); PDFDB with WO-1 slow-released system (group E); PDFDB material combined with WO-1 slow-released system and osteoblasts (group F) were implanted in bilateral lower limbs of 36 Newzealand rabbits respectively (6 rabbits in each groups). Histological, histochemical and biochemical analysis were detected 2, 4, 6, 8 weeks after operation.</p><p><b>RESULTS</b>Within the observation periods, no osteogenesis was observed in group A. The osteogenesis in group B, D, F were superior to that of group C and E (P < 0.05). The osteogenetic activity in group C and E was delayed. The quantity and quality of osteogenesis in group D and F were 2 weeks ahead of time compared with group B, and 4 weeks to that of group C and E. The newborn calcification content was superior to that of group A, C, and E (P < 0.05).</p><p><b>CONCLUSIONS</b>The osteogenesis of PDFDB materials with BMP/TGF-beta or WO-1 is slower than that of which combined with osteoblasts. Simple material PDFDB has no ectopic osteogenesis.</p>


Subject(s)
Animals , Child , Female , Humans , Rabbits , Bone Morphogenetic Proteins , Pharmacology , Bone Substitutes , Pharmacology , Drug Synergism , Lactic Acid , Pharmacology , Osteogenesis , Polyesters , Polymers , Pharmacology , Recombinant Proteins , Pharmacology , Swine , Tissue Engineering , Transforming Growth Factor beta , Pharmacology
2.
Acta Academiae Medicinae Sinicae ; (6): 276-280, 2002.
Article in Chinese | WPRIM | ID: wpr-278183

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the feasibility of life span extension of transformed human embryonic tendon cells (THETC) by reconstitution of the telomerase activity.</p><p><b>METHODS</b>THETC were transfected by pGRN145 plasmid containing the human telomerase reverse transcriptase (hTERT) cNDA in vitro by molecular cloning technique. The biological characteristics of transfected cells were detected and compared by morphological observation, plate cloning efficiency, soft agar culture, growth curve of cells cultured in different conditions, immunohistochemistry, telomerase activity assay by telomeric repeat amplification protocol (TRAP).</p><p><b>RESULTS</b>The THETC transfected by pGRN145 plasmid (telT) could express the telomerase activity with extension of life span. The telT maintained the original characteristics of temperature-dependant and serum-dependant, as well as secretion of type I collagen normally and without tendency of malignant transformation.</p><p><b>CONCLUSIONS</b>The life span of THETC can be prolonged by reconstitution of telomerase activity, which provides the novel experimental methods to establish the standard cells line.</p>


Subject(s)
Humans , Cell Line , Cell Survival , Embryo, Mammalian , Plasmids , Genetics , RNA-Directed DNA Polymerase , Telomerase , Genetics , Metabolism , Tendons , Cell Biology , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL